Revenue: The sum of all revenue fields included for a company's operating activities.
Genmab A/S (GNMSF) had Revenue of $3.12B for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$3.12B |
$1.14B |
|
$142.82M |
|
$2.98B |
|
$2.15B |
|
$971.94M |
|
$356.85M |
|
$1.33B |
|
$1.33B |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
$1.14B |
|
$971.94M |
|
$1.03B |
|
64.19M |
|
64.63M |
|
$17.72 |
|
$17.60 |
|
| Balance Sheet Financials | |
$4.04B |
|
$141.81M |
|
$2.60B |
|
$6.64B |
|
$769.66M |
|
-- |
|
$551.87M |
|
$1.32B |
|
$5.32B |
|
$3.16B |
|
$5.32B |
|
66.19M |
|
| Cash Flow Statement Financials | |
$1.13B |
|
$-1.44B |
|
$-568.25M |
|
$2.16B |
|
$1.43B |
|
$-726.30M |
|
$104.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.42% |
|
31.14% |
|
31.14% |
|
33.06% |
|
42.57% |
|
36.44% |
|
$1.10B |
|
-- |
|
-- |
|
-- |
|
0.47 |
|
15.89 |
|
3.22 |
|
113.45 |
|
21.38% |
|
35.95% |
|
17.12% |
|
21.38% |
|
$80.39 |
|
$17.01 |
|
$17.43 |
|